Peer-influenced content. Sources you trust. No registration required. This is HCN.

HealthlineHormone Therapy May Help Improve Menopause Brain Fog, Mood Changes

⚠️ Small Study / Early Comparative Evidence

Consumer coverage combines three distinct evidence signals around menopausal hormone therapy: early studies of cognitive and mood symptoms and a much larger dementia-risk analysis. A 20-person uncontrolled case series reported improved cognitive symptoms after estriol plus progesterone, while a 260-person study reported lower psychological symptom scores after hormone therapy. Separately, a meta-analysis of more than 1 million women found neither increased nor decreased dementia risk. These findings should not be interpreted as establishing MHT for cognitive or mood indications.


Patient Counseling Points

  • The 20-person cognitive case series had no placebo group or randomization, making reported improvement an early clinical signal rather than established treatment efficacy.
  • In the 260-person mood study, severe mood symptoms decreased from 62.3% to 24.6% after hormone therapy, but the study was not presented as establishing MHT as treatment for depression.
  • Cognitive complaints during menopause and dementia are different clinical questions; improvement in short-term symptoms does not establish dementia prevention.
  • The cited meta-analysis of more than 1 million women found neither increased nor decreased dementia risk associated with MHT.
  • Hormone therapy decisions should therefore not be reframed around presumed cognitive protection or treatment of brain fog based on these studies alone.

Patient Care Applications

  • Clarify that emerging cognitive findings do not establish an approved treatment indication for menopausal brain fog.
  • Discuss cognitive and mood symptoms within the patient’s broader menopause assessment rather than assuming they arise solely from hormonal change.
  • Interpret MHT benefits according to established indications and individualized benefit-risk assessment, not dementia prevention.
  • Avoid translating improvement in small observational studies into claims that hormone therapy improves cognition broadly.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form